ARCHIVES

FDA Approves Tamoxifen For “Reduction In Incidence,” Avoids Word “Prevention”

This article is from The Cancer Letter archive.

Vol. 24 No. 42 | November 6, 1998

Download PDF Visit The Full Archive

Related Articles

DeVita Era At NCI One Of New Programs, Remarkable Stability

August 19, 1988

Guest Editorial: MD Anderson’s Judith Smith Questions NCI Short-Term Remedy For Carboplatin Dosing

October 15, 2010

New Treatment Approach To Treating Brain Tumor

April 26, 2002

Atlas Showing County Cancer Rates Available

July 18, 1975

Organizations Ask Senate To Increase NCI Appropriations, Order OMB To “Get Nose Out Of Tent”

May 2, 1986

Lymphoseek Label Updated To Include Head and Neck SCC

June 27, 2014